Nordic Biomarker has been awarded as the Export Success of the Year in Sweden 2022.
The prize was awarded August 31, by Minister of Foreign Trade Anna Hallberg in the presence of H.K.H. Prince Daniel.
The first Alumni of Umeå Biotech Incubator
Nordic Biomarker develops, manufactures and sells reagents for coagulation diagnostics. The company, who was the first Alumni of Umeå Biotech Incubator, and its subsidiaries have grown rapidly in recent years. According to the award jury, the company has today a turnover of 130 million SEK and has approximately 80 employees, of which almost 50 of these are situated in the newly built and customized premises in Umeå.
“It’s really fun to get some national attention. Everyone puts a lot of commitment into this and this gives everyone a boost at the same time as we are strengthened in our belief that we are on the right path,” stated Rikard Rodén, CEO Nordic Biomarker, last week when the company was presented as one of three nominees for the award.
A strong, genuine Swedish ability to innovate that saves lives
With the award, initiated in 2021, the Government wants to draw attention to Swedish exports and especially small and medium-sized companies.
The winner motivation was: “In recent years, Nordic Biomarker has demonstrated an impressive growth rate and a strong, genuine Swedish ability to innovate that saves lives. The company, with its all-Swedish research and production, is a role model in its sector. The fact that almost all production is exported to leading medical technology companies helps Sweden to end up on the international map in life science. I am proud of our Swedish small and medium-sized companies that are internationalizing”.
Photo of H.K.H. Prince Daniel, Rikard Rodén, CEO Nordic Biomarker, and Minister of Foreign Trade Anna Hallberg. Photographer: Frida Drake/Regeringskansliet
